• FDA Approves Xermelo drugs.com
    March 01, 2017
    FDA Approves Xermelo (telotristat ethyl) as First and Only Oral Treatment for Carcinoid Syndrome Diarrhea in Cancer Patients with Metastatic Neuroendocrine Tumors
PharmaSources Customer Service